<DOC>
	<DOCNO>NCT02178839</DOCNO>
	<brief_summary>The Objective This Study Evaluating Effect oral β- glucan Supplement Anthropometric Measurements , Appetite , Insulin Resistance , Liver echogenicity Enzymes Non Alcoholic Fatty Liver Patients Treating Hypocaloric Diet Vitamin E .</brief_summary>
	<brief_title>The Effect Oral β- Glucan Supplement Appetite Insulin Resistance Non Alcoholic Fatty Liver Disease</brief_title>
	<detailed_description />
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Fatty Liver</mesh_term>
	<mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Patients Non Alcoholic Fatty Liver Disease From Both Sex Age 1855 year BMI 25 Kg/m2 Alcohol Consumption Pregnancy lactation menopause Being professional athlete A history cancer Risk high blood pressure ( case drug use ) Heart disease cardiovascular , pulmonary , renal diabetes Liver transplantation chronic acute Liver diseases hepatitis B , C liver infections The History inherited disorder affect liver A history autoimmune disease History food allergy Taking certain medication blood pressure control , statin , insulin sensitivity enhancer hepatotoxic drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Non Alcoholic Fatty Liver Disease ( NAFLD )</keyword>
	<keyword>β- glucan</keyword>
	<keyword>Appetite</keyword>
	<keyword>Insulin Resistance</keyword>
</DOC>